Category: Manufacturing

April 8, 2021

The rising popularity of outsourcing implementations across the healthcare industry due to the benefits such as affordability and less-time consumption will serve as a vital growth prospect for the pharmaceutical contract development and manufacturing market during the forecast period of […]

April 5, 2021

Emergent BioSolutions Inc. (NYSE:EBS) today announced that the Company continues to be on track with its manufacturing agreements related to COVID-19 vaccines and confirmed that there are no changes to its financial guidance for 2021. In addition, the Company received […]

March 29, 2021

EMA’s human medicines committee (CHMP) has adopted several important recommendations that will increase manufacturing capacity and supply of COVID-19 vaccines in the EU. New manufacturing site for AstraZeneca’s COVID-19 vaccine A new manufacturing site has been approved for the production […]

March 26, 2021

Lincolnshire, Illinois—Nexus Pharmaceuticals, Inc. is pleased to announce that it has received authorization to occupy its new pharmaceutical manufacturing facility from the Village of Pleasant Prairie, Wisconsin. Nexus Pharmaceuticals, which specializes in developing innovative processes to manufacture specialty and generic […]

March 3, 2021

Chondroitin sulfate is an important structural component of cartilage and is naturally found in connective tissues in the human body and in animal cartilage. It is part of a protein molecule that helps give cartilage its elastic properties and is […]

February 11, 2021

As part of the agreement, Rentschler will invest in the site over the next five years to bolster their manufacturing capabilities. This investment is expected to make a ‘major contribution’ to creating suitable manufacturing capability for cell and gene therapies, […]

February 3, 2021

Researchers from the Los Angeles-based Terasaki Institute for Biomedical Innovation (TIBI) say they have successfully designed a method for rapid testing large numbers of potential immunotherapy drugs against live tumor cells for accurate and easily analyzable data. They began by […]

February 1, 2021

In a joint press briefing today together with German Health Minister Jens Spahn, Minister-President of North Rhine-Westphalia, Armin Laschet, and Chief Executive Officer of CureVac N.V., Franz-Werner Haas, Member of the Board of Management, Bayer AG and President of the […]

January 14, 2021

Cognate BioServices, Inc.., the premier commercial-ready, global CDMO in the Cell and Gene Therapy industry, announced today its plans to expand cell and gene therapy manufacturing capacity, laboratory space, warehousing capabilities, and increase office support at its facilities in the […]

January 5, 2021

Transplanted stem cells have been used as regenerative therapies for decades. In cancer, for example, they can restore the body’s ability to create the red blood cells, white blood cells, and platelets after chemotherapy. But stem cells have wider therapeutic […]

December 4, 2020

With Pfizer’s and Moderna’s vaccines proving highly protective against COVID-19 in large clinical trials, planning to roll out and distribute the two shots throughout the U.S. has kicked into high gear. The vaccines are expected to be authorized shortly after […]

December 3, 2020

Viveve, Inc. (NASDAQ:VIVE), a medical technology company focused on women’s intimate health, today announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) expanding manufacturing capacity for its consumable treatment tips used with the Company’s Cryogen-cooled Monopolar Radiofrequency (CMRF) […]